Press release
Global Microbial Fermentation Technology Market Size was USD 33,956.10 million in 2024 at a CAGR of 5.24% by 2032, Evaluates DelveInsight
According to DelveInsight's analysis, The microbial fermentation technology market is experiencing strong growth, largely due to the increasing incidence of chronic illnesses such as cancer and a range of infectious diseases, including HIV, hepatitis B and C, and influenza. The market is also being boosted by the rising need for advanced therapeutic products like cell therapies, monoclonal antibodies, recombinant proteins, and gene therapies. Moreover, progress in synthetic biology and precision fermentation is improving production efficiency, scalability, and product quality, further accelerating adoption. Together with continuous advancements in bioprocessing techniques, these factors are expected to drive notable market expansion throughout the 2025-2032 forecast period.DelveInsight's "Microbial Fermentation Technology Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Microbial Fermentation Technology companies actively working in the market.
To know more about why North America is leading the market growth in the Microbial Fermentation Technology market, get a snapshot of the report Microbial Fermentation Technology Market Trends
https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Microbial Fermentation Technology Overview
Microbial fermentation technology is a bioprocess in which microorganisms such as bacteria, yeast, or fungi are used to convert organic materials into useful products. Through controlled fermentation conditions-like temperature, pH, and oxygen levels-these microbes produce enzymes, antibiotics, vaccines, biofuels, amino acids, vitamins, and other industrial or pharmaceutical compounds.
This technology plays a key role in sectors such as biopharmaceuticals, food and beverages, agriculture, bioenergy, and environmental management, enabling large-scale and cost-effective production of biologically derived materials.
DelveInsight Analysis: The microbial fermentation technology market size was valued at USD 33,956.10 million in 2024 and is anticipated to expand at a CAGR of 5.24% over the forecast period from 2025 to 2032.
Microbial Fermentation Technology Market Insights
Geographically, North America is expected to lead the microbial fermentation technology market throughout the 2025-2032 forecast period. This dominance is driven by factors such as the growing incidence of infectious diseases like tuberculosis, influenza, and new emerging pathogens, along with a rising number of cancer cases. In addition, strong R&D activity, the presence of major industry players, and a highly developed healthcare infrastructure further reinforce the region's market leadership.
To read more about the latest highlights related to Microbial Fermentation Technology, get a snapshot of the key highlights entailed in the Microbial Fermentation Technology Insights
https://www.delveinsight.com/report-store/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Microbial Fermentation Technology Market Report
• In June 2024, Danone, Michelin, DMC Biotechnologies, and Crédit Agricole Centre France collaborated to establish the Biotech Open Platform, a cutting-edge biotechnology hub aimed at advancing large-scale precision fermentation. This initiative enhanced the development of bio-based materials and ingredients by leveraging advanced microbial fermentation processes.
• In March 2024, Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA in genetic medicines, announced a partnership with Culture Biosciences to advance scalable fermentation process development for its proprietary NBx PlatformTM.
• Thus, owing to such developments in the market, rapid growth will be observed in the Microbial Fermentation Technology market during the forecast period
Key Players in the Microbial Fermentation Technology Market
Some of the key market players operating in the Microbial Fermentation Technology market include- Novozymes A/S, Lonza Group AG, Koninklijke DSM N.V., Biocon Limited, Ajinomoto Co., Inc., Evonik Industries AG, Intralytix, Inc., UAS Laboratories LLC, Second Genome, Inc., Chr. Hansen Holding A/S, Ginkgo Bioworks, Amyris, Inc., Lesaffre, BioVectra Inc.TerraVia Holdings, Inc., and others.
Which MedTech key players in the Microbial Fermentation Technology market are set to emerge as the trendsetter explore @ Key Microbial Fermentation Technology Companies
https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Microbial Fermentation Technology Market Landscape
Global health organizations and regulatory agencies are increasingly contributing to the growth of the antibiotics market. Groups such as the Global Antibiotic Research & Development Partnership (GARDP), the U.S. Biomedical Advanced Research and Development Authority (BARDA), and the European Innovative Medicines Initiative (IMI) are investing in and supporting antibiotic research and development. These initiatives are essential for tackling the growing threat of antimicrobial resistance (AMR) and ensuring access to effective treatments.
With the combined impact of rising infectious disease rates, escalating AMR concerns, ongoing technological progress, and strong governmental and institutional support, the antibiotics segment is expected to witness substantial growth. This momentum will play a key role in driving the expansion of the overall microbial fermentation technology market throughout the 2025-2032 forecast period.
Scope of the Microbial Fermentation Technology Market Report
• Coverage: Global
• Study Period: 2022-2032
• Microbial Fermentation Technology Market Segmentation By Product Type: Antibiotics, Probiotics, Monoclonal Antibodies, Biosimilar, Recombinant Proteins & Vaccines, Enzymes, and Others
• Microbial Fermentation Technology Market Segmentation By End-User: Pharmaceutical & Biotechnology Industry, Contract Research Organizations (CROs), CMOs & CDMOs, and Academic & Research Institutions
• Microbial Fermentation Technology Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Microbial Fermentation Technology Companies: Novozymes A/S, Lonza Group AG, Koninklijke DSM N.V., Biocon Limited, Ajinomoto Co., Inc., Evonik Industries AG, Intralytix, Inc., UAS Laboratories LLC, Second Genome, Inc., Chr. Hansen Holding A/S, Ginkgo Bioworks, Amyris, Inc., Lesaffre, BioVectra Inc.TerraVia Holdings, Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Microbial Fermentation Technology market will grow by 2032? Click to get a snapshot of the Microbial Fermentation Technology Market Analysis
https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Microbial Fermentation Technology Market Size was USD 33,956.10 million in 2024 at a CAGR of 5.24% by 2032, Evaluates DelveInsight here
News-ID: 4253732 • Views: …
More Releases from DelveInsight Business Research
Endogenous Cushing's Syndrome Market Insights Highlight Expanding Outlook Till 2 …
DelveInsight's "Endogenous Cushing's Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Endogenous Cushing's Syndrome, historical and forecasted epidemiology as well as the Endogenous Cushing's Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Endogenous Cushing's Syndrome, offering comprehensive insights into the Endogenous Cushing's Syndrome revenue trends,…
Lamellar Ichthyosis Market to Experience Notable Growth in Forecast Span by 2034 …
DelveInsight's "Lamellar Ichthyosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lamellar Ichthyosis, historical and forecasted epidemiology as well as the Lamellar Ichthyosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Lamellar Ichthyosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lamellar Ichthyosis Market Forecast
https://www.delveinsight.com/sample-request/lamellar-ichthyosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Global Anti-retropulsion Devices Market to grow at a CAGR of 6.69% by 2032, Eval …
According to DelveInsight's analysis, The rising demand for anti-retropulsion devices is mainly driven by the increasing incidence of kidney stones, often associated with factors like dehydration. Additionally, the growing prevalence of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles-which significantly contribute to kidney stone formation-further supports market growth. Advances in anti-retropulsion device technology, coupled with ongoing R&D initiatives by key industry players, are also playing a…
Global Blood Gas and Electrolyte Analyzers Market to grow at a CAGR of 5.65% to …
According to DelveInsight's analysis, The demand for blood gas and electrolyte analyzers is largely fueled by the rising prevalence of chronic conditions, including cardiovascular, respiratory, and kidney diseases, as well as diabetes ailments that are increasingly common in the aging population. Furthermore, the growing adoption of Point-of-Care Testing (POCT) allows for quicker, on-site diagnosis, supporting market growth. Technological innovations, such as compact, portable, and automated analyzers, along with new product…
More Releases for Microbial
Microbial Contamination Identification Market Size Analysis by Application, Type …
According to Market Research Intellect, the global Microbial Contamination Identification market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for microbial contamination identification is expanding steadily due to growing concerns about product safety in industries…
Major Market Shift in Microbial Identification Industry: Automated Systems Trans …
What Is the Forecasted Market Size and Growth Rate for the Microbial Identification Market?
In the last few years, the size of the microbial identification market has seen significant expansion. It is projected to rise from $5.57 billion in 2024 to $6.44 billion in 2025, with a compound annual growth rate (CAGR) of 15.7%. The exponential growth during the historic period is credited to initiatives and funding from the government which…
Microbial Food Ingredient Market Harvesting the Power of Microbes: The Booming M …
Microbial Food Ingredient Market Worth 4.97 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Microbial Food Ingredient Market"- By Microorganism (Bacteria, Yeast, Mold), Product Type (Starter Cultures, Protective Cultures, Probiotic Cultures), Strain (Single-Strain Culture, Multi-Strain Culture, Multi-Strain Mixed Culture) End User (Food and Beverage Manufacturers, Animal Feed Additives), Industry Trends, and Global Forecasts, 2022-2035 And…
Microbial Identification Market: Unraveling Microbial Mysteries on the Path to U …
The global microbial identification market is expected to be worth US$ 3.7 billion in 2022, and to grow at a CAGR of 11.3% between 2022 and 2032, to be worth around US$ 10.7 billion by 2032. Rising demand for microbial identification products across various end-user sectors such as pharmaceutical and biotechnology, food and beverage, water and environment, diagnostic laboratories, and independent research laboratories is driving the microbial identification market.
Based on…
Microbial Fermentation Technology Market
According to the report, the global microbial fermentation technology market was valued at US$1,493.8 bn in 2016 and is projected to expand at a CAGR of 5.7% from 2017 to 2025, rising to a valuation of US$2,447.5 bn in 2025.
Market Definition:
When fungus and other microbes create secondary metabolites, microbial fermentation takes place. When the conditions are ideal, these bacteria may convert affordable nitrogen and carbon sources into crucial intermediates or…
Microbial Bioreactor Market
The Global Microbial Bioreactor Market is expected to grow at a CAGR of 20.1% during the forecasting period (2022-2029).
Micro bioreactors serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology process development and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors…
